SGRY logo

Surgery Partners, Inc. Stock Price

NasdaqGS:SGRY Community·US$2.0b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

SGRY Share Price Performance

US$15.95
-6.79 (-29.86%)
US$17.95
Fair Value
US$15.95
-6.79 (-29.86%)
11.2% undervalued intrinsic discount
US$17.95
Fair Value
Price US$15.95
AnalystConsensusTarget US$17.95
AnalystHighTarget US$23.49
AnalystLowTarget US$14.00

SGRY Community Narratives

·
Fair Value US$17.95 11.2% undervalued intrinsic discount

Outpatient Shifts And CMS Changes Will Expand Surgical Potential

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
·
Fair Value US$23.49 32.1% undervalued intrinsic discount

Aging Population And Minimally Invasive Advances Will Fuel Outpatient Demand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$14 13.9% overvalued intrinsic discount

Leverage And CMS Shifts Will Curb Earnings Yet Spark Recovery

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$23.49
32.1% undervalued intrinsic discount
Profit Margin
3.57%
Future PE
28.38x
Price in 2029
US$30.71
US$17.95
11.2% undervalued intrinsic discount
Profit Margin
1.84%
Future PE
44.35x
Price in 2029
US$23.67

Trending Discussion

No trending discussion available.

Updated Narratives

SGRY logo

SGRY: Q1 Execution And 2026 Outlook Will Support Margin Recovery

Fair Value: US$23.49 32.1% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SGRY logo

SGRY: Reset Expectations And Steady Guidance Will Shape Future Multiple Potential

Fair Value: US$14 13.9% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SGRY logo

SGRY: Margin Repair And Payer Mix Reset Will Support 2026 EBITDA Recovery

Fair Value: US$17.95 11.2% undervalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with adequate balance sheet.

0 Risks
3 Rewards

Surgery Partners, Inc. Key Details

US$3.3b

Revenue

US$2.6b

Cost of Revenue

US$763.3m

Gross Profit

US$839.4m

Other Expenses

-US$76.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.59
22.83%
-2.28%
80.4%
View Full Analysis

About SGRY

Founded
2004
Employees
16000
CEO
J. Evans
WebsiteView website
www.surgerypartners.com

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Recent SGRY News & Updates

Recent updates

No updates